NASDAQ:CERS Cerus (CERS) Stock Price, News & Analysis $2.00 +0.11 (+5.53%) As of 01:14 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cerus Stock (NASDAQ:CERS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cerus alerts:Sign Up Key Stats Today's Range$1.88▼$2.0950-Day Range$1.86▼$2.6752-Week Range$1.47▼$3.47Volume2.45 million shsAverage Volume2.17 million shsMarket Capitalization$404.91 millionP/E RatioN/ADividend YieldN/APrice Target$5.25Consensus RatingHold Company Overview Cerus Corporation is a biomedical products company focused on improving the safety of blood components used for transfusions. Its primary offering is the INTERCEPT Blood System, which uses a pathogen-reduction process designed to inactivate a broad range of viruses, bacteria, parasites and white blood cells in donated blood components. INTERCEPT is used to process platelet and plasma components. Cerus also develops related processing devices and supplies for blood centers and transfusion services. The company’s work has centered on reducing the risk of transfusion-transmitted infections and supporting the availability of treated blood products. Founded in 1991, Cerus serves blood centers and healthcare organizations in the United States and international markets. Its products are subject to regulatory approvals and availability can vary by geography.AI Generated. May Contain Errors. Read More Cerus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreCERS MarketRank™: 2.292689398965 of 5 starsCerus scored higher than 46% of companies evaluated by MarketBeat, and ranked 295th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingCerus has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialCerus has a consensus price target of $5.25, representing about 161.8% upside from its current price of $2.01.Amount of Analyst CoverageCerus has only been the subject of 2 research reports in the past 90 days.Read more about Cerus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cerus are expected to grow in the coming year, from ($0.02) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cerus is -66.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cerus is -66.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCerus has a P/B Ratio of 5.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.65% of the float of Cerus has been sold short.Short Interest Ratio / Days to CoverCerus has a short interest ratio ("days to cover") of 8.18.Change versus previous monthShort interest in Cerus has recently decreased by 12.01%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCerus does not currently pay a dividend.Dividend GrowthCerus does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Cerus this week, compared to 3 articles on an average week.Search Interest4 people have searched for CERS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added Cerus to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cerus insiders have not sold or bought any company stock.Percentage Held by Insiders5.30% of the stock of Cerus is held by insiders.Percentage Held by Institutions78.37% of the stock of Cerus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cerus' insider trading history. Receive CERS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CERS Stock News HeadlinesCerus Corporation (NASDAQ:CERS) Stock Has Average Price Target of $5.25November 13, 2026 | americanbankingnews.comWall Street Zen Upgrades Cerus (NASDAQ:CERS) to BuyNovember 7, 2026 | americanbankingnews.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 18 at 1:00 AM | Profits Run (Ad)Cerus: 3 key takeaways for long-term investorsNovember 3, 2026 | msn.comCerus (CERS) Q3 2026 Earnings Call TranscriptNovember 3, 2026 | finance.yahoo.comCerus Buy Rating Maintained at $4 on Positive Phase 3 RBC Results and Strong Q3 ExecutionNovember 3, 2026 | tipranks.comCerus Corporation (CERS) Q3 2026 Earnings Call TranscriptNovember 3, 2026 | seekingalpha.comCerus Corp (CERS) Q3 2026 Earnings Call Highlights: Revenue Climbs 10% as Adjusted EBITDA ...November 3, 2026 | finance.yahoo.comSee More Headlines CERS Stock Analysis - Frequently Asked Questions How have CERS shares performed this year? Cerus' stock was trading at $2.06 at the beginning of the year. Since then, CERS stock has decreased by 2.7% and is now trading at $2.0050. How were Cerus' earnings last quarter? Cerus Corporation (NASDAQ:CERS) released its quarterly earnings results on Thursday, July, 30th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.00. The biotechnology company earned $63.30 million during the quarter, compared to analysts' expectations of $62.90 million. Cerus had a negative net margin of 3.23% and a negative trailing twelve-month return on equity of 10.44%. Read the conference call transcript. Who are Cerus' major shareholders? Cerus' top institutional shareholders include State Street Corp (2.52%), Sumitomo Mitsui Trust Group Inc. (2.23%), Goldman Sachs Group Inc. (1.26%) and Ieq Capital LLC (1.24%). Insiders that own company stock include William Mariner Greenman, Vivek K Jayaraman, Kevin Dennis Green, Chrystal Jensen, Richard J Benjamin, Carol Moore, Eric Bjerkholt, Daniel N Swisher Jr and Hua Shan. View institutional ownership trends. How do I buy shares of Cerus? Shares of CERS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cerus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cerus investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), NVIDIA (NVDA), OPKO Health (OPK), Alibaba Group (BABA), Bristol Myers Squibb (BMY) and Nokia (NOK). Company Calendar Last Earnings7/30/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 13 days, CERS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNASDAQ:CERS CIK1020214 Webwww.cerus.com Phone(925) 288-6000Fax925-288-6001Employees345Year Founded1991Price Target and Rating Average Price Target for Cerus$5.25 High Price Target$6.50 Low Price Target$4.00 Potential Upside/Downside+163.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.03) Trailing P/E RatioN/A Forward P/E Ratio199.50 P/E GrowthN/ANet Income-$15.63 million Net Margins-3.23% Pretax Margin-3.10% Return on Equity-10.44% Return on Assets-3.42% Debt Debt-to-Equity Ratio0.46 Current Ratio1.96 Quick Ratio1.15 Sales & Book Value Annual Sales$206.13 million Price / Sales1.95 Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book5.25Miscellaneous Outstanding Shares201,950,000Free Float191,250,000Market Cap$402.89 million OptionableOptionable Beta1.84 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:CERS) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.